| |||
 | |||
 |
Creatine | ||
| |||
| Pronunciation |
 (eth
il nor ep i NEF
rin) |
 |
| U.S. Brand Names |
| Bronkephrine® Injection |
|
| Generic Available |
|
No |
|
| Synonyms |
| Ethylnorepinephrine Hydrochloride |
|
| Pharmacological Index |
|
Alpha/Beta Agonist |
|
| Use |
|
Bronchial asthma and reversible bronchospasm |
|
| Pregnancy Risk Factor |
|
C |
|
| Contraindications |
|
Cardiac arrhythmias; hypersensitivity to ethylnorepinephrine or any component |
|
| Adverse Reactions |
|
>10%: Cardiovascular: Tachycardia, pounding heart beat Central nervous system: Nervousness, trembling Gastrointestinal: Nausea Neuromuscular & skeletal: Tremor 1% to 10%: Cardiovascular: Hypertension or hypotension Central nervous system: Dizziness, lightheadedness, headache, insomnia, drowsiness Dermatologic: Flushing of face Gastrointestinal: Xerostomia, heartburn, vomiting, abnormal taste Genitourinary: Dysuria Neuromuscular & skeletal: Muscle cramping, weakness Respiratory: Coughing Miscellaneous: Increased diaphoresis |
|
| Stability |
|
Protect from light |
|
| Usual Dosage |
|
I.M., S.C.: Adults: 0.5-1 mL |
|
| Mental Health: Effects on Mental Status |
|
Nervousness is common; may cause insomnia, drowsiness, confusion, anxiety, or psychosis |
|
| Mental Health: Effects on Psychiatric Treatment |
|
None reported |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Dosage Forms |
|
Injection, as hydrochloride: 2 mg/mL (1 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
